Abstract:Background and objective Mutations in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene could reduce the enzyme activity and lead to hyperhomocysteinemia, a condition that has been associated with several vascular conditions, in particular, coronary artery disease and deep vein thrombosis. The aim of this study was to assess the prevalence of the most common polymorphisms, C677T, which have not been well studied in hypertensives. Methods A total of 456 hypertensives from 6 cities distributed widely from north to south in China were studied. DNA samples were isolated from peripheral blood samples and genotyped using PCR-RFLP method. Homocysteine and folate concentrations were also examined. Results The frequency of CC, CT and TT genotypes in Chinese hypertensives was 25.1%, 49.8%, and 25.1%, respectively. Overall, the frequency of allele T was 50%, though it varied significantly across 6 Chinese cities. The frequency of TT homozygous was 14.6% among southern hypertensives and 29.7% among northern hypertensives. The difference was statistically significant (p<0.01). In both Northern and Southern subjects, TT homozygotes had significantly higher plasma Hcy levels and lower folate than those with CC or CT genotypes. Conclusion Compared with other populations reported so far, Chinese hypertensives, especially in Northern cities, had the highest frequency of allele T of MTHFR C677T polymorphism. Background and objective Mutations in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene could reduce the enzyme activity and lead to hyperhomocysteinemia, a condition that has been associated with several vascular conditions, in particular, coronary artery disease and deep vein thrombosis. The aim of this study was to assess the prevalence of the most common polymorphisms, C677T, which have not been well studied in hypertensives. Methods A total of 456 hypertensives from 6 cities distributed widely from north to south in China were studied. DNA samples were isolated from peripheral blood samples and genotyped using PCR-RFLP method. Homocysteine and folate concentrations were also examined. Results The frequency of CC, CT and TT genotypes in Chinese hypertensives was 25.1%, 49.8%, and 25.1%, respectively. Overall, the frequency of allele T was 50%, though it varied significantly across 6 Chinese cities. The frequency of TT homozygous was 14.6% among southern hypertensives and 29.7% among northern hypertensives. The difference was statistically significant (p<0.01). In both Northern and Southern subjects, TT homozygotes had significantly higher plasma Hcy levels and lower folate than those with CC or CT genotypes. Conclusion Compared with other populations reported so far, Chinese hypertensives, especially in Northern cities, had the highest frequency of allele T of MTHFR C677T polymorphism.

Homocysteine Level and N5,10-methylenetetrahydrofolate Reductase Gene Polymorphism in Hypertensive Population

Association of a Methylene Tetrahydrofolate Reductase C677T Polymorphism with Several Blood Chemical Levels in a Chinese Population

Relationship between MTHFR C677T Polymorphisms and Susceptibility of Digestive System Cancer and Coronary Heart Disease

Methylenetetrahydrofolate Reductase C677t Gene Polymorphisms in Chinese Hypertensives

Effect of methylenetetrahydrofolate reductase C677T polymorphism on serum folate but not vitamin B12 levels in patients with H-type hypertension

Individual and Joint Associations of Methylenetetrahydrofolate Reductase C677T Genotype and Plasma Homocysteine With Dyslipidemia in a Chinese Population With Hypertension.

Associations of Homocysteine Status and Homocysteine Metabolism Enzyme Polymorphisms with Hypertension and Dyslipidemia in a Chinese Hypertensive Population.

Association Study of MTHFR C677T Genotype with H-type Hypertension

A Meta-Analysis of Association Between C677T Polymorphism in the Methylenetetrahydrofolate Reductase Gene and Hypertension

Association between serum 5-methyltetrahydrofolate and homocysteine in Chinese hypertensive participants with different MTHFR C677T polymorphisms: a cross-sectional study

Systemic Risk Factors Correlated with Hyperhomocysteinemia for Specific MTHFR C677T Genotypes and Sex in the Chinese Population

The C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene is Associated with the Level of Decrease on Diastolic Blood Pressure in Essential Hypertension Patients Treated by Angiotensin-Converting Enzyme Inhibitor

Methylenetetrahydrofolate Reductase C677t Polymorphism, Hypertension And Risk Of Stroke: A Prospective, Nested Case-Control Study

Predicting Hyperhomocysteinemia by Methylenetetrahydrofolate Reductase C677t Polymorphism in Chinese Patients with Hypertension

Associations of Methylenetetrahydrofolate Reductase C677T Genotype with Blood Pressure Levels in Chinese Population with Essential Hypertension

Elevated Serum Homocysteine,mthfr Gene Mutation and Essential Hypertension in Chinese

Clinical Study on Effect of Common Methylenetetrahydrofolate Reductase Gene Mutation on Coronary Artery Disease in Hypertension

Evidence on the Causal Link Between Homocysteine and Hypertension from a Meta-Analysis of 40 173 Individuals Implementing Mendelian Randomization.

Homocysteine and All-Cause Mortality in Hypertensive Adults Without Pre-Existing Cardiovascular Conditions: Effect Modification by MTHFR C677T Polymorphism.

Methylenetetrahydrofolate Reductase C677T Polymorphism, Hypertension, and Risks of Stroke: A Prospective Nested Case–control Study

Methylenetetrahydrofolate Reductase C677T Polymorphism is Associated with Estimated Glomerular Filtration Rate in Hypertensive Chinese Males